Trial intelligence / Profile preview

Comparison of triamcinolone oral paste versus licorice oral paste for minor aphthous lesions

IRCT20210519051341N1Phase 3Completed

Sponsor
Qazvin University of Medical Sciences
Start
Aug 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, triple-blind trial of triamcinolone and licorice extract in aphthosis (RAS) (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Ulcer pain reduction and Ulcer healing time. Started Aug 2021; status: completed.

02

Drugs

triamcinolonelicorice extract
03

Conditions

aphthosis (RAS)

Beyond the preview

Go deeper on IRCT20210519051341N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210519051341N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call